Corrected Data. In the Original Contribution entitled "Major Cardiovascular Events in Hypertensive Patients Randomized to Doxazosin vs Chlorthalidone: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)" published in the April 19, 2000, issue of THE JOURNAL (2000;283:1967-1975), data that were reported have since been corrected. The original reported number of 42 448 participants and 625 sites changed because 30 patients with poor documentation of informed consent were excluded. This also changed the original reported numbers of 15 268 participants in the chlorthalidone group and 9067 participants in the doxazosin group (a total of 24 335) to 15 255 and 9061, respectively (a total of 24 316). In addition, the original article reported a sample size of 10 337 for the lipid-lowering trial component of ALLHAT. This was a typographical error and should have been 10 357. However, due to the deletion of participants from the database, this number is now 10 355.
In addition, losses to follow-up were reported as 501 patients in the chlorthalidone group and 338 patients in the doxazosin group. This has been changed to losses of 545 patients and 361 patients, respectively, because the authors modified the definition of loss to follow-up. Originally, the definition was based on declaration of loss by a clinic site. The new definition includes this plus vital status unknown at trial closeout, the period of October 15, 1999, through February 15, 2000.
Deaths were ascertained through February 15, 2000, by clinic report or by match with an entry in databases from the Center for Medicare and Medicaid Services, the Department of Veterans Affairs, the National Death Index, or the Social Security Administration with a confirmatory death certificate. The additional lost individuals were not known to be dead or to have had a closeout visit after October 15, 1999. The authors identified additional deaths in both the doxazosin (n = 769) and chlorthalidone (n = 1258) groups before the cutoff date of February 15, 2000.
Despite these changes, the outcome analyses remain essentially the same and all statistically significant results remain so.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.